Amazing results. And similarish kind of method to cf33,
https://www.cgoncology.com/pipeline/"Cancer-selective oncolytic immunotherapy designed for tolerability and potency
CG0070 is an investigational oncolytic immunotherapy based on a modified common cold adenovirus backbone that contains a cancer-specific promoter and a GM-CSF transgene. CG0070 was designed to work in two important and complementary ways. First, it replicates inside the tumor’s cells causing tumor cell lysis and immunogenic cell death. Then, the rupture of the cancer cells can release tumor-derived antigens, along with GM-CSF, that can stimulate a systemic anti-tumor immune response that involves the body’s own white blood cells. The scientific rationale and clinical profile of CG0070 make it an ideal agent to be developed for a variety of solid tumor types to be used alone or in combination with immune checkpoint modulators."
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-5843
-
- There are more pages in this discussion • 10,000 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M |
Open | High | Low | Value | Volume |
4.9¢ | 5.0¢ | 4.9¢ | $900.1K | 18.37M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
102 | 15456501 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 1713619 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
102 | 15456501 | 0.048 |
63 | 7620458 | 0.047 |
37 | 4709023 | 0.046 |
53 | 5098365 | 0.045 |
10 | 892291 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 1713619 | 8 |
0.051 | 1155393 | 5 |
0.052 | 1099239 | 8 |
0.053 | 1164182 | 8 |
0.054 | 1092392 | 7 |
Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online